Nantahala Capital Management, LLC Nektar Therapeutics Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
A detailed history of Nantahala Capital Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 7,810,000 shares of NKTR stock, worth $8.28 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
7,810,000
Previous 4,110,000
90.02%
Holding current value
$8.28 Million
Previous $5.34 Million
35.93%
% of portfolio
0.37%
Previous 0.32%
Shares
3 transactions
Others Institutions Holding NKTR
# of Institutions
152Shares Held
131MCall Options Held
92.7KPut Options Held
4.9K-
Black Rock Inc. New York, NY15.2MShares$16.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$13.1 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.67MShares$10.2 Million0.14% of portfolio
-
Acadian Asset Management LLC Boston, MA7.2MShares$7.63 Million0.02% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$7.05 Million0.12% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $199M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...